Abstract
BackgroundJuvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in childhood. Recent advances in biologics have greatly changed the prognosis of JIA.ObjectivesTo evaluate the efficacy and safety of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
